The anticonvulsants carbamazepine and sodium valproate have efficacy i
n hypomania, bipolar depression and in the prophylaxis of bipolar diso
rder. This paper reviews published evidence on the effects of the new
anticonvulsants gabapentin and lamotrigine in bipolar disorder. The co
nclusion is that there is good evidence from open studies to indicate
that randomised double-blind trials of these compounds should be carri
ed out. The pharmacology of these anticonvulsants is reviewed and puta
tive predictors of good response identified.